Inventor
SUJINO KEIKO
CA17 patents
⚠️ This page may combine multiple inventors who share the name “SUJINO KEIKO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD CALISTOGA LLC
8 patentsUS8865730B2Oct 21, 2014
Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
GILEAD CALISTOGA LLC25 citations91
US10414737B2Sep 17, 2019
Process methods for phosphatidylinositol 3-kinase inhibitors
GILEAD CALISTOGA LLC5 citations82
US10059677B2Aug 28, 2018
Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereof
GILEAD CALISTOGA LLC8 citations82
US10047060B2Aug 14, 2018
Process methods for phosphatidylinositol 3-kinase inhibitors
GILEAD CALISTOGA LLC7 citations82
US9567337B2Feb 14, 2017
Process methods for phosphatidylinositol 3-kinase inhibitors
GILEAD CALISTOGA LLC10 citations82
US9469643B2Oct 18, 2016
Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
GILEAD CALISTOGA LLC9 citations82
US10730879B2Aug 4, 2020
Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
GILEAD CALISTOGA LLC2 citations71
US10954199B2Mar 23, 2021
Process methods for phosphatidylinositol 3-kinase inhibitors
GILEAD CALISTOGA LLC0 citations61
GILEAD SCIENCES INC
3 patentsUS10196419B2Feb 5, 2019
Processes and intermediates for preparing anti-HIV agents
GILEAD SCIENCES INC1 citations71
US9296779B2Mar 29, 2016
Processes and intermediates for preparing anti-HIV agents
GILEAD SCIENCES INC3 citations70
US9783567B2Oct 10, 2017
Processes and intermediates for preparing anti-HIV agents
GILEAD SCIENCES INC1 citations61